Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: DEXORGEN INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-07 to 2023-03-23
Current total value of award: $24750
Description: CONSTRUCT 293T STABLE CELL LINES THAT STABLY EXPRESS SARS2 SPIKE WASHINGTON, DELTA AND OMICRON VARISNTS AND MCHERRY FLUORESCENCE PROTEIN.